Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1106-1110

  Born, Jan ^a,b   Steinbach, Dirk ^a   Dodt, Christoph ^a   Fehm, Horst Lorenz ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF BAMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANRENOATE POTASSIUM; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; PLACEBO; RECEPTOR BLOCKING AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NIGHT SLEEP; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SLOW WAVE SLEEP; WAKEFULNESS;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALDOSTERONE ANTAGONISTS; CANRENOATE POTASSIUM; CENTRAL NERVOUS SYSTEM; CORTICOTROPIN-RELEASING HORMONE; DRUG SYNERGISM; HUMANS; HYDROCORTISONE; MALE; PITUITARY-ADRENAL SYSTEM; RECEPTORS, MINERALOCORTICOID; SLEEP; SLEEP STAGES;

EID: 0030905067     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.1106     Document Type: Article

References (29)

1. Van Cauter E, Turek FW. 1995 Endocrine and other biological rhythms. In: DeGroot LJ, ed. Endocrinology, Vol 3. Philadelphia: Saunders; 2487-2548.
2. Weitzman ED, Nogeire C, Perlow M, et al. 1974 Effects of a prolonged 3-hour sleep-wake cycle on sleep stages, plasma cortisol, growth hormone and body temperature in man. J Clin Endocrinol Metab. 38:1018-1030.
3. Van Cauter E, Blackman JD, Roland D, Spire JP, Refetoff S, Polonsky KS. 1991 Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest. 88:934-942.
4. Pietrowsky R, Meyrer R, Kern W, Born J, Fehm HL. 1994 Effects of diurnal sleep on secretion of cortisol, luteinizing hormone, and growth hormone in man. J Clin Endocrinol Metab. 78:683-687.
5. Bierwolff C, Struve K, Marshall L, Born J, Fehm HL. Slow wave sleep drives inhibition of pituitary-adrenal secretion in humans. J Neuroendocrinol. In press.
6. Späth-Schwalbe E, Uthgenannt D, Voget G, Kern W, Born J, Fehm HL. 1993 Corticotropin-releasing-hormone induced ACTH and cortisol secretion depends on sleep and wakefulness. J Clin Endocrinol Metab. 77:1170-1173.
7. Späth-Schwalbe E, Uthgenannt D, Körting N, Fehm HL, Born J. 1994 Sleep and wakefulness affect the responsiveness of the pituitary-adrenocortical axis to arginine vasopressin in humans. Neuroendocrinology. 60:544-548.
8. De Kloet ER. 1941 Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol. 12:95-164.
9. Dallman MF, Levin N, Cascio CS, Akana SF, Jacobsen L, Kuhn W. 1989 Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. Endocrinology. 124:2844-2850.
10. Reul JMHM, van den Bosch JR, de Kloet ER. 1987 Differential response of type 1 and type 2 corticosteroid receptors to change to plasma steroid level and circadian rhythmicity. Neuroendocrinology. 45:407-412.
11. Joels M, De Kloet ER. 1994 Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol. 43:1-36.
12. Ratka A, Sutanto W, Bloemers M, De Kloet ER. 1989 On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulations. Neuroendocrinology. 50:117-123.
13. Dodt C, Kern W, Fehm HL, Born J. 1993 Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary adrenal (HPA) axis in humans. Neuroendocrinology. 58:570-574.
14. Rechtschaffen A, Kales A. 1968 A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. NIH 204. Washington DC: US Government Printing Office.
15. Dixon WJ. 1992 BMDP statistical software, Los Angeles: University of California Press.
16. Follenius M, Brandenberger G, Muzet A. 1985 ACTH-provoked cortisol peaks during sleep and their effect on the endogenous secretory activity. Horm Metab Res. 17:602-606.
17. Salata RA, Jarrett DB, Verbalis JG, Robinson AG. 1988 Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. J Clin Invest. 81:766-774.
18. Späth-Schwalbe E, Fehm HL, Born J, Pfeiffer EF. 1987 Combined corticotropin-releasing hormone - vasopressin test:a new test for the evaluation of the pituitary adrenal system. Horm Metab Res. 19:665-666.
19. Cheng SC, Suzuki K, Sadée W, Harding BW. 1976 Effects of spironolactone, canrenone and canrenoate-K on cytochrome p450 and 11β and 18-hydroxylation in bovine and human adrenal cortical mitochondria. Endocrinology. 99:1097-1106.
20. Abshagen U, Spörl S, Schöneshöfer M, Láge M, Oelkers W. 1978 Interferences of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism. Klin Wochenschr. 56:341-349.
21. Jackson EK. 1996 Diuretics. In: Hardman JG, Limberd LE, eds. Goodman and Gilman's. The pharmacological basis of therapeutics. New York: McGraw-Hill, 685-713.
22. Kuhlmann J, Kötter V, Rietbrock N. 1977 Canrenoate disposition in dogs. Tissue distribution and elimination. Naunyn Schmiedebergs Arch Pharmacol. 298:181-187.
23. 3H-labelled spironolactone compound in the dog. Eur J Pharmacol. 21:238-341.
24. Suemaro S, Darlington DN, Akana SE, Cascio CS, Dallman MF. 1995 Ventromedial hypothalamic lesions inhibit corticosteroid feedback regulation of basal ACTH during the trough of the circadian rhythm. Neuroendocrinology. 61:453-463.
25. Reul JMHM, DeKloet ER, Van Sluijs FJ, Rijnberk A, Rothuizen J. 1990 Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology. 127:907-915.
26. Spencer RL, Young EA, Choo PH, McEwen BS. 1990 Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid. Brain Res. 514:37-48.
27. Born J, DeKloet R, Wenz H, Kern W, Fehm HL. 1991 Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors. Am J Physiol. 260:E183-188.
28. Weitzman ED, Zimmerman JC, Czeisler CA, Ronda J. 1983 Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab. 56:352-358.
29. Born J, Muth S, Fehm HL. 1988 The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology. 13:233-243.